Article Text

Download PDFPDF
Why we should stop using animal-derived products on patients without their consent
  1. Daniel Rodger
  1. Institute of Health and Social Care, London South Bank University, School of Allied and Community Health, London SE1 0AA, UK
  1. Correspondence to Daniel Rodger, Institute of Health and Social Care, London South Bank University, School of Allied and Community Health, London SE1 0AA, UK; daniel.rodger{at}lsbu.ac.uk

Abstract

Medicines and medical devices containing animal-derived ingredients are frequently used on patients without their informed consent, despite a significant proportion of patients wanting to know if an animal-derived product is going to be used in their care. Here, I outline three arguments for why this practice is wrong. First, I argue that using animal-derived medical products on patients without their informed consent undermines respect for their autonomy. Second, it risks causing nontrivial psychological harm. Third, it is morally inconsistent to respect patients’ dietary preferences and then use animal-derived medicines or medical devices on them without their informed consent. I then address several anticipated objections and conclude that the continued failure to address this issue is an ethical blind spot that warrants applying the principles of respect for autonomy and informed consent consistently.

  • applied and professional ethics
  • clinical ethics
  • education for health care professionals
  • ethics
  • paternalism

Data availability statement

There are no data in this work.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Twitter @philosowhal

  • Contributors DR is the sole author.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Other content recommended for you